Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Prophylaxis of Atrial Fibrillation After Mitral Valve Surgery
NCT07482540Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Jun 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
01
Overview
Randomised trial in Atrial fibrillation (AFib) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Incidence rate of post operative new onset atrial fibrillation at 72 hours. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07482540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07482540.